# OZEMPIC
> **NDA209637** · New Drug Application · Sponsor: NOVO · Approved 2017-12-05
## Drug
- **FDA Application Number:** NDA209637
- **Application type:** New Drug Application
- **Brand name:** OZEMPIC
- **Generic name:** SEMAGLUTIDE
- **Active ingredients:** SEMAGLUTIDE
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** NOVO
- **Manufacturer:** Novo Nordisk
- **First approval:** 2017-12-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209637)
---
*AI Analytics · CC0 1.0*